TAVI in patients with low-flow low-gradient aortic stenosis-short-term and long-term outcomes.
Julius SteffenNikolas ReißigDavid AndreaeMarkus BeckmannMagda HaumJulius FischerHans TheissDaniel BraunMartin OrbanKonstantinos RizasSebastian SadoniMichael NäbauerSven PeterssJörg HausleiterSteffen MassbergSimon DeseivePublished in: Clinical research in cardiology : official journal of the German Cardiac Society (2022)
While 3-year mortality remains high after TAVI in LFLG compared to HG patients, symptoms improve in all subsets after TAVI.
Keyphrases
- aortic stenosis
- ejection fraction
- transcatheter aortic valve implantation
- transcatheter aortic valve replacement
- aortic valve
- aortic valve replacement
- left ventricular
- end stage renal disease
- coronary artery disease
- newly diagnosed
- chronic kidney disease
- peritoneal dialysis
- type diabetes
- cardiovascular events
- prognostic factors
- cardiovascular disease
- heart failure
- peripheral blood
- sleep quality
- living cells
- depressive symptoms
- aqueous solution